Skip to content
Screener

Enanta Pharmaceuticals ENTA Q3 2025 Annual earnings

Reported November 17, 2025 · Before market open

Revenue$15.1MMiss by $845.6K
EPS-$0.87Beat by $0.26
Revenue estimate$16.0M
EPS estimate-$1.13

Next report

Nov 16, 2026 (in 2 months)
Revenue estimate$15.7M
EPS estimate-$0.77

FAQ

When did Enanta Pharmaceuticals report Q3 2025 earnings?
Enanta Pharmaceuticals (ENTA) reported Q3 2025 earnings on November 17, 2025 before market open.
What were Enanta Pharmaceuticals's Q3 2025 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $15.1M and eps of $-0.87 for Q3 2025.
Did Enanta Pharmaceuticals beat estimates in Q3 2025?
Revenue missed the consensus estimate of $16.0M by $845.6K. EPS beat the consensus estimate of $-1.13 by $0.26.
How did Enanta Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 77.6% from $67.6M a year earlier and eps grew 36.0% from $-1.36.
Where can I find Enanta Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-284633) and the 10-K periodic report (0001193125-25-288121) directly on SEC EDGAR. The filing index links above go to sec.gov.